Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (351-360 of 434) with videos related to

Pageof 44
Sort By:
Interactive Journal of Medical Research|May 25, 2022
Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative AnalysisIrena Doubelt, Jason M Springer, Tanaz A Kermani, et al.
The Journal of Rheumatology|September 3, 2015
Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT ProcessJoanna C Robson, Nataliya Milman, Gunnar Tomasson, et al.
Annals of the Rheumatic Diseases|December 2, 2015
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA typeSebastian Unizony, Miguel Villarreal, Eli M Miloslavsky, et al.
Arthritis and Rheumatism|December 30, 2006
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192Christopher P Denton, Peter A Merkel, Daniel E Furst, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 17, 2016
Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3Lynn A Fussner, Amber M Hummel, Darrell R Schroeder, et al.
European Journal of Internal Medicine|May 15, 2015
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and managementMatthieu Groh, Christian Pagnoux, Chiara Baldini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 22, 2014
Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitisSebastian Unizony, Noha Lim, Deborah J Phippard, et al.
ACR Open Rheumatology|May 25, 2021
Clinical Manifestations and Long-Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North AmericaIrena Doubelt, David Cuthbertson, Simon Carette, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trialMarco Matucci-Cerinic, Christopher P Denton, Daniel E Furst, et al.
Arthritis and Rheumatism|October 2, 2002
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenonPeter A Merkel, Karen Herlyn, Richard W Martin, et al.
Pageof 44

Showing results (351-360 of 434) with videos related to

Sort By:
Pageof 44
Interactive Journal of Medical Research|May 25, 2022
Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative AnalysisIrena Doubelt, Jason M Springer, Tanaz A Kermani, et al.
The Journal of Rheumatology|September 3, 2015
Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT ProcessJoanna C Robson, Nataliya Milman, Gunnar Tomasson, et al.
Annals of the Rheumatic Diseases|December 2, 2015
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA typeSebastian Unizony, Miguel Villarreal, Eli M Miloslavsky, et al.
Arthritis and Rheumatism|December 30, 2006
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192Christopher P Denton, Peter A Merkel, Daniel E Furst, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 17, 2016
Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3Lynn A Fussner, Amber M Hummel, Darrell R Schroeder, et al.
European Journal of Internal Medicine|May 15, 2015
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and managementMatthieu Groh, Christian Pagnoux, Chiara Baldini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 22, 2014
Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitisSebastian Unizony, Noha Lim, Deborah J Phippard, et al.
ACR Open Rheumatology|May 25, 2021
Clinical Manifestations and Long-Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North AmericaIrena Doubelt, David Cuthbertson, Simon Carette, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trialMarco Matucci-Cerinic, Christopher P Denton, Daniel E Furst, et al.
Arthritis and Rheumatism|October 2, 2002
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenonPeter A Merkel, Karen Herlyn, Richard W Martin, et al.
Pageof 44